Intraperitoneal immunotherapy for metastatic ovarian carcinoma: Resistance of intratumoral collagen to antibody penetration

被引:93
作者
Choi, J
Credit, K
Henderson, K
Deverkadra, R
He, Z
Wiig, H
Vanpelt, H
Flessner, MF
机构
[1] Univ Mississippi, Med Ctr, Dept Med, Div Nephrol, Jackson, MS 39216 USA
[2] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA
[3] Univ Bergen, Dept Biomed, Bergen, Norway
关键词
D O I
10.1158/1078-0432.CCR-05-2141
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Convective transport of macromolecules from the peritoneal cavity into tumor is determined by its hydraulic permeability and the pressure gradient. Previous studies showed that establishing a pressure gradient into the tumor failed to result in significant penetration. This study addresses the hypothesis that the extracellular matrix is the major resistance to the penetration of an i.p. injected antibody. Experimental Design: Human ovarian tumors (SKOV-3 and OVCAR-3) were established in the abdominal wall of athymic rats. After anesthesia, the tumor serosal surface was treated for 2 hours with Krebs solution (control), collagenase (37.5 unit/mL), or hyaluronidase (10 unit/mL) followed by 3 hours of convective delivery of radiolabeled IgG. Transport of antibody into the tumor was measured with quantitative autoradiography along with the tumor interstitial pressure, concentration of collagen and hyaluronic acid, and IgG volume of distribution. Results: Antibody was excluded from 42% to 53% of tumor extracellular volume. Exposure of tumors to hyaluronidase did not enhance IgG transport despite removal of 90% of the hyaluronan from the exposed tumor. In contrast, collagenase reduced collagen content, lowered tumor interstitial pressure, and markedly enhanced antibody penetration. Conclusions: Reduction of collagen, but not hyaluronan, in the matrix of ovarian xenografts enhanced the transport of i.p. injected antibody. Although high interstitial pressure is a deterrent to convective transport of macromolecules into the tumor parenchyma, the structure of the interstitial matrix provides an inherent resistance, which must be overcome before effective delivery of an antibody.
引用
收藏
页码:1906 / 1912
页数:7
相关论文
共 45 条
[1]   Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer [J].
Alberts, DS ;
Liu, PY ;
Hannigan, EV ;
OToole, R ;
Williams, SD ;
Young, JA ;
Franklin, EW ;
ClarkePearson, DL ;
Malviya, VK ;
DuBeshter, B ;
Adelson, MD ;
Hoskins, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (26) :1950-1955
[2]   Intraperitoneal radioimmunotherapy of ovarian cancer with Lu-177-CC49: A phase I/II study [J].
Alvarez, RD ;
Partridge, EE ;
Khazaeli, MB ;
Plott, G ;
Austin, M ;
Kilgore, L ;
Russell, CD ;
Liu, TP ;
Grizzle, WE ;
Schlom, J ;
LoBuglio, AF ;
Meredith, RF .
GYNECOLOGIC ONCOLOGY, 1997, 65 (01) :94-101
[3]   Intraperitoneal chemotherapy for ovarian carcinoma: Results of long-term follow-up [J].
Barakat, RR ;
Sabbatini, P ;
Bhaskaran, D ;
Revzin, M ;
Smith, A ;
Venkatraman, E ;
Aghajanian, C ;
Hensley, M ;
Soignet, S ;
Brown, C ;
Soslow, R ;
Markman, M ;
Hoskins, WJ ;
Spriggs, D .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :694-698
[4]  
Brekken C, 2000, ANTICANCER RES, V20, P3513
[5]   Uptake of IgG in osteosarcoma correlates inversely with interstitial fluid pressure, but not with interstitial constituents [J].
Davies, CD ;
Engesæter, BO ;
Haug, I ;
Ormberg, IW ;
Halgunset, J ;
Brekken, C .
BRITISH JOURNAL OF CANCER, 2001, 85 (12) :1968-1977
[6]  
DEDRICK RL, 1978, CANCER TREAT REP, V62, P1
[7]  
DEDRICK RL, 1989, CANC IMMUN, V2, P429
[8]   Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts [J].
Eikenes, L ;
Bruland, OS ;
Brekken, C ;
Davies, CDL .
CANCER RESEARCH, 2004, 64 (14) :4768-4773
[9]   PERITONEAL ABSORPTION OF MACROMOLECULES STUDIED BY QUANTITATIVE AUTORADIOGRAPHY [J].
FLESSNER, MF ;
FENSTERMACHER, JD ;
BLASBERG, RG ;
DEDRICK, RL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 248 (01) :H26-H32
[10]  
Flessner MF, 1996, J AM SOC NEPHROL, V7, P225